The Global Biologics Components Market size was valued at USD 412 Billion in 2024 and is projected to reach USD 612 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.25% during the forecast period, i.e., 2025-2030. According to MarkNtel Advisors Study.
Global Biologics Components Market Driver:
Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth – Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.
Thus, with enhanced investment, the process of pre-commercialization and market launch has been accelerated, which has been contributing to the market growth. Also, over the historical years, the approvals of these medicines have been accelerated by government organizations like the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), etc. Consequently, as approvals for cell and gene therapies would accelerate in the coming years, it would create an opportunity for their enhanced adoption in the coming years as well.
Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html
Key Market Reports Highlights
- Market Dimensions & Projections
- Pricing Evaluation
- Recent Strategic Moves by Companies
- Primary Stakeholders
- Import/Export Trend Analysis
- Competitive Landscape Assessment
- Emerging Opportunities
- Market Trends and Indicators
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Browse Full Report including(TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/global-biologics-market.html
Global Biologics Components Market Segmentation:
The market report categorizes the market based on different segments and geographical analysis.
Study Timeline:
-Base Year: 2024
-Historical Period: 2020 to 2023
-Forecast Period: 2025 to 2030
- By Therapeutic Application
- Oncology- Market Size & Forecast 2020-2030, (USD Million)
- Infectious Disease- Market Size & Forecast 2020-2030, (USD Million)
- Autoimmune Disease- Market Size & Forecast 2020-2030, (USD Million)
- Diabetes- Market Size & Forecast 2020-2030, (USD Million)
- Cardiovascular Diseases- Market Size & Forecast 2020-2030, (USD Million)
- Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2020-2030, (USD Million)
- By Drug Class
- Recombinant Proteins- Market Size & Forecast 2020-2030, (USD Million)
- Hormones- Market Size & Forecast 2020-2030, (USD Million)
- Cytokines- Market Size & Forecast 2020-2030, (USD Million)
- Monoclonal Antibodies- Market Size & Forecast 2020-2030, (USD Million)
- Blood & Blood Components- Market Size & Forecast 2020-2030, (USD Million)
- Cellular & Gene Therapy- Market Size & Forecast 2020-2030, (USD Million)
- Vaccines- Market Size & Forecast 2020-2030, (USD Million)
- Others- Market Size & Forecast 2020-2030, (USD Million)
- Recombinant Proteins- Market Size & Forecast 2020-2030, (USD Million)
- By Source
- Microbes- Market Size & Forecast 2020-2030, (USD Million)
- Humans- Market Size & Forecast 2020-2030, (USD Million)
- Others (Rodents, Plants, etc.)- Market Size & Forecast 2020-2030, (USD Million)
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Competitive Landscape
With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including – Bristol-Myers Squibb, Pfizer, Sanofi, Janssen Biotech, Inc., Bayer AG, Merck & Co., Amgen Inc., Abbott GmbH, Novartis, AstraZeneca Plc, GlaxoSmithKline Biologicals, Moderna, Inc., Ferring Pharmaceuticals Inc., Aimmune Therapeutics, Inc., F. Hoffman La Roche, and Others are looking forward to strengthening their market positions.
Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/global-biologics-market.html
Global Biologics Components Industry Recent Development:
2023: Amgen announced the completion of the acquisition of biologics market player, Horizon Therapeutics, which is aligned with its vision for the development of drugs for patients with rare diseases.
2023: AstraZeneca Plc. announced that the Ministry of Health, Labour, and Welfare in Japan approved the extended utilization of Soliris (eculizumab) biologics in the treatment of pediatric patients laid low with generalized myasthenia gravis, particularly those who have no longer responded nicely to different treatment options.
Data-Driven Insights Backed by Proven Research
We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.
From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us
MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com
Latest Press Release – https://www.marknteladvisors.com/press-release
